• Welcome to Crohn's Forum, a support group for people with all forms of IBD. While this community is not a substitute for doctor's advice and we cannot treat or diagnose, we find being able to communicate with others who have IBD is invaluable as we navigate our struggles and celebrate our successes. We invite you to join us.

Ibd-aid

Anyone familiar with the research going on at U of Mass using a modification of the SCD? It is called IBD-AID. I would like to find someone who was/ in the trail and can tell me more about the diet in specific terms. Evidently it is very promising.
Here is a link to the ABSTRACT:

Pilot Testing a Novel Treatment for Inflammatory Bowel Disease
http://www.umassmed.edu/uploadedFiles/MBD_Poster59_EDITED_5-15-2011.pdf

More info:

http://www.scdrecipe.com/blog/archive/2011/12/29/exciting-umass-study-planned-obsolescence-site/

and:
Big News out of UMASS: New Study on SCD-like Diet Shows Huge Promise for Treating IBD

http://foodrx.org/2012/01/big-news-...ike-diet-shows-huge-promise-for-treating-ibd/
 

David

Co-Founder
Location
Naples, Florida
This case series indicates the potential for the IBD-AID to be used as an adjunctive or alternative therapy for the treatment ofIBD.Notably, 9 out of 11 patients were able to be managed without anti-TNF therapy, and 100% of the patients had their symptoms reduced. To make clear recommendations for its use in clinical practice, randomized trials are neededalongside strategies to improve acceptability and compliance with the IBD-AID.
Very nice :)

A small study but the data continues to showcase that diet matters for many.
 
http://www.nutritionj.com/content/13/1/5

An anti-inflammatory diet as treatment for inflammatory bowel disease: a case series report


Abstract
Background
The Anti-Inflammatory Diet (IBD-AID) is a nutritional regimen for inflammatory bowel disease (IBD) that restricts the intake of certain carbohydrates, includes the ingestion of pre- and probiotic foods, and modifies dietary fatty acids to demonstrate the potential of an adjunct dietary therapy for the treatment of IBD.

Methods
Forty patients with IBD were consecutively offered the IBD-AID to help treat their disease, and were retrospectively reviewed. Medical records of 11 of those patients underwent further review to determine changes in the Harvey Bradshaw Index (HBI) or Modified Truelove and Witts Severity Index (MTLWSI), before and after the diet.

Results
Of the 40 patients with IBD, 13 patients chose not to attempt the diet (33%). Twenty-four patients had either a good or very good response after reaching compliance (60%), and 3 patients’ results were mixed (7%). Of those 11 adult patients who underwent further medical record review, 8 with CD, and 3 with UC, the age range was 19–70 years, and they followed the diet for 4 or more weeks. After following the IBD-AID, all (100%) patients were able to discontinue at least one of their prior IBD medications, and all patients had symptom reduction including bowel frequency. The mean baseline HBI was 11 (range 1–20), and the mean follow-up score was 1.5 (range 0–3). The mean baseline MTLWSI was 7 (range 6–8), and the mean follow-up score was 0. The average decrease in the HBI was 9.5 and the average decrease in the MTLWSI was 7.

Conclusion
This case series indicates potential for the IBD-AID as an adjunct dietary therapy for the treatment of IBD. A randomized clinical trial is warranted.
 
Top